Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates: British Journal of Pharmacology

Anne Filppula

doi:10.1111/j.1476-5381.2011.01732.x

Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates: British Journal of Pharmacology

Anne Filppula

Pharmacy

Research output: Contribution to journal › Article › Scientific › peer-review

81 Citations (Scopus)

Original language	English
Journal	British Journal of Pharmacology
DOIs	https://doi.org/10.1111/j.1476-5381.2011.01732.x
Publication status	Published - 2012
MoE publication type	A1 Journal article-refereed

Access to Document

10.1111/j.1476-5381.2011.01732.x

Cite this

@article{c6a765001f284189a8d759e29ca790aa,

title = "Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates: British Journal of Pharmacology",

author = "Anne Filppula",

year = "2012",

doi = "10.1111/j.1476-5381.2011.01732.x",

language = "English",

journal = "British Journal of Pharmacology",

issn = "0007-1188",

publisher = "Wiley",

}

TY - JOUR

T1 - Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates

T2 - British Journal of Pharmacology

AU - Filppula, Anne

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1476-5381.2011.01732.x

DO - 10.1111/j.1476-5381.2011.01732.x

M3 - Article

SN - 0007-1188

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

ER -